DUBLIN--(BUSINESS WIRE)--The "Ophthalmic Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global ophthalmic drugs market to grow with a CAGR of 5.4% over the forecast period of 2017-2023. The study on ophthalmic drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2015 to 2023.
The report on ophthalmic drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global ophthalmic drugs market over the period of 2015 to 2023.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global ophthalmic drugs market over the period of 2015 to 2023. Further, Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
Key Topics Covered
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Ophthalmic Drugs Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.5. Competitive Landscape in the Global Ophthalmic Drugs Market
4. Global Ophthalmic Drugs Market by Disease Condition
4.3. Dry Eye Disorder
4.4. Retinal Disorder
5. Global Ophthalmic Drugs Market by Dispense Type
5.2. Over the Counter
6. Global Ophthalmic Drugs Market by Region 2017-2023
6.1. North America
7. Company Covered
7.1. Abbott Healthcare
7.2. Allergan Plc
7.3. Johnson & Johnson
7.5. Valeant Pharmaceuticals, Inc.
7.6. Pfizer, Inc.
7.7. Merck & Co.
7.8. Novartis AG
7.10. Santen Pharmaceuticals Company Ltd.
For more information about this report visit https://www.researchandmarkets.com/research/m7x9rg/ophthalmic_drugs?w=4